Tablet Amitriptyline 10 milligrams
Phase 3Small molecule
Tablet Amitriptyline 10 milligrams is one of 20 small molecule programs targeting Dyspepsia. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
19
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
25 competitors in Dyspepsia
#DrugCompanyPhaseTrials
1Prevacid
TakedaApproved
Buspar
Bristol-Myers SquibbApproved
Nexium
DDexcel Pharma Technologies Ltd.
Approved
Protonix
WWyeth-Lederle Vaccines
Approved
Prilosec
DDexcel Pharma Technologies Ltd.
Approved
Resotran
TakedaApproved
Pepcid
KKenvue Brands
Approved
Osmitrol
BB. Braun Medical Inc.
Approved
Pulmicort
SSalix
Approved
Clostridium Butyricum
XXijing Hospital of Digestive Diseases
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- MMd. Moktadirul Hoque Shuvo